Title: How Science Is Advancing Beyond Viagra to Treat Erectile Dysfunction

Erectile disorder (ED) affects millions of men worldwide, including up to one in four in the United States, and extends beyond physical functioning to impact sexual confidence, self-esteem, relationship satisfaction, and overall quality of life. While prevalence increases with age, age alone does not explain ED, as medical conditions such as diabetes, cardiovascular disease, and the after-effects of surgery—particularly prostate surgery—can disrupt erectile functioning. Psychological contributors like performance anxiety, stress, and relational concerns are also common and often interact with biological factors, making ED a complex condition rather than a single, isolated problem.

Treatment for erectile dysfunction currently relies most often on medication, sex therapy, or a combination of both. Phosphodiesterase type 5 inhibitors, such as Viagra and Cialis, are widely prescribed and work by increasing blood flow to the penis in response to sexual stimulation. Their on-demand dosing and ease of oral use make them appealing, but they are not appropriate for everyone. Certain medical conditions, side effects, concerns about reduced spontaneity, lack of efficacy, or cost can limit their usefulness for some patients.

Sex therapy offers another well-established treatment option. It can help individuals and couples reduce performance anxiety, improve communication and sexual satisfaction, and rebuild sexual confidence. However, access to sex therapy remains uneven due to cost, waitlists, geographic limitations, and stigma, which prevent many people from receiving timely care.

At the same time, technology is transforming how ED is assessed and treated. From app-connected devices to immersive virtual-reality environments, new tools are expanding both research and clinical possibilities. These advances support a future in which ED is understood and treated with greater precision, nuance, and compassion, moving beyond the traditional reliance on medication alone.

A new approach highlighted in recent research may further change the treatment landscape. A drug under investigation has shown potential to restore sexual function for months after just three days of dosing, offering hope for men who do not respond to existing therapies. While still emerging, such developments reflect ongoing efforts to address the unmet needs of those affected by erectile disorder through innovative scientific approaches.